re.Mind Capital

What is re.Mind Capital?

re.Mind Capital is a prominent early-stage investment fund dedicated to the intersection of mental health, brain health, and human flourishing.

They actively invest in startups that are operating across several dynamic sectors which include BioTech, FinTech & Financial Services, Hardware & Manufacturing, Sales & Marketing, HealthTech & Fitness, Medical Devices & Hospital Services, Healthcare & Wellness, Consumer, and Pharmaceutical & Medicine.

With a commitment to nurturing innovative ideas that can reshape the landscape of health and well-being, re.Mind Capital focuses on Seed and Pre-seed stages of company development.

The fund has defined financial parameters for its investments, with a minimum investment threshold of $100,000, a maximum cap of $5,000,000, and a 'sweet spot' investment size of around $1,500,000.

By positioning themselves in this range, they aim to empower emerging companies that have the potential to make significant contributions to their respective fields while ensuring that these companies have the guidance and support they need in their critical early phases of growth.

Their portfolio reflects a diverse range of innovative ventures designed to promote better health outcomes and facilitate cutting-edge solutions within their focus industries. Their approach is tailored to the unique needs of startups in these high-impact sectors, providing not only funding but also valuable industry expertise and connections. Based out of offices in London and Malta, re.Mind Capital is poised as a pivotal player in the early-stage investment ecosystem, especially for ventures striving to enhance mental and brain health and overall human well-being.

What they say:

We are a fund established by Christian Angermayer and partners Jan Hardorp and Max de Vere.

What we look for: We invest in various innovative ventures.